The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Autotaxin facilitates selective LPA receptor signaling
Open accessPublished version of a preprint
Abstract
Autotaxin (ATX; ENPP2) produces the lipid mediator lysophosphatidic acid (LPA) that signals through disparate EDG (LPA 1-3 ) and P2Y (LPA 4-6 ) G protein-coupled receptors. ATX/LPA promote several (patho)physiological processes, including in pulmonary fibrosis, thus serving as attractive drug targets. However, it remains unclear if clinical outcome depends on how different ATX inhibitors modulate the ATX/LPA signaling axis. Here, we show that inhibitors binding to the ATX “tunnel” specifically abrogate key aspects of ATX/LPA signaling. We find that the tunnel is essential for signaling efficacy and dictates cellular responses independent of ATX catalytic activity, with a preference for activation of P2Y LPA receptors. These responses are abrogated by tunnel-binding inhibitors, such as ziritaxestat, but not by inhibitors that exclusively target the active site, as shown in primary lung fibroblasts and a murine model of radiation-induced pulmonary fibrosis. Our results uncover a receptor-selective signaling mechanism for ATX, implying clinical benefit for tunnel-targeting ATX inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015) · SoftwareX · doi:10.1016/j.softx.2015.06.001 · Cited by 27,190
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
REFMAC 5 for the refinement of macromolecular crystal structures
Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M., Long, F., & Vagin, A. A. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911001314 · Cited by 8,415
Varadi, M., Anyango, S., Deshpande, M., Nair, S., Natassia, C., Yordanova, G., Yuan, D., Stroe, O., Wood, G., Laydon, A., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1061 · Cited by 7,850
Molecular replacement with MOLREP
Vagin, A. A., & Teplyakov, A. (2009) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042589 · Cited by 3,669
Integration, scaling, space-group assignment and post-refinement
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047374 · Cited by 2,564
Cited by
Sorted by citations
Lysophosphatidic acid, a simple phospholipid with myriad functions
Yanagida, K., & Shimizu, T. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108421 · Cited by 51
Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis
Volkmann, E. R., Denton, C. P., Kolb, M. R. J., Wijsenbeek-Lourens, M. S., Emson, C. L., Hudson, K. J., Amatucci, A. J., Distler, O., Allanore, Y., & Khanna, D. (2024) · European Respiratory Review · doi:10.1183/16000617.0015-2024 · Cited by 28
Yan, J., Duan, W., Gao, Q., Mao, T., Wang, M., Duan, J., & Li, J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106877 · Cited by 27
Yu, Y., Li, Z., Cai, Y., Guo, J., Lin, Y., & Zhao, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063305 · Cited by 19
A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis
Booijink, R. S., Salgado-Polo, F., Jamieson, C., Anastassis Perrakis, A., & Bansal, R. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216333 · Cited by 20
Self-citationExperimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis
Simonetti, J., Ficili, M., Sgalla, G., & Richeldi, L. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2305126 · Cited by 18
A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages
Ren, Y., Wang, M., Yuan, H., Wang, Z., & Yu, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112319 · Cited by 17
Lu, L., Hu, X., Yang, H., Wang, H., Tian, Z., Zhang, Y., & Wang, X. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00675-6 · Cited by 13
Lysophosphatidic acid metabolism and signaling in heart disease
Jose, A., Fernando, J. J., & Kienesberger, P. C. (2024) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2024-0077 · Cited by 14
The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders
Dedoni, S., Camoglio, C., Siddi, C., Scherma, M., Fratta, W., & Fadda, P. (2024) · Future Pharmacology · doi:10.3390/futurepharmacol4010014 · Cited by 10
Briand‐Mésange, F., Gennero, I., Salles, J., Trudel, S., Dahan, L., Ausseil, J., Payrastre, B., Salles, J., & Chap, H. (2024) · Molecules · doi:10.3390/molecules29153694 · Cited by 10
Discovery of potent chromone-based autotaxin inhibitors inspired by cannabinoids
Eymery, M., Nguyen, K.-A., Basu, S., Hausmann, J., Tran‐Nguyen, V., Seidel, H., Gutierrez, L., Boumendjel, A., & McCarthy, A. A. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115944 · Cited by 9
The Emerging Role of LPA as an Oncometabolite
Karalis, T. T., & Poulogiannis, G. (2024) · Cells · doi:10.3390/cells13070629 · Cited by 8
Volat, F., Medhi, R., Maggs, L. Z., Deken, M. A., Price, A., Andrews, L., Clark, J., Taylor, D., Carruthers, A. M., Taylor-Smith, E., et al. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0522 · Cited by 10
Novel Circulating Biomarkers in Aortic Valve Stenosis
Ong, J. Y.-S., Tan, S. M. L., Koh, A. S.-M., Kong, W. K. F., Sia, C., Yeo, T. C., Quek, S. C., & Poh, K. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051902 · Cited by 6
Ma, D., Zhao, B. T., Yue, L., Li, S., Wei, X., Jiang, N., Zang, L., Lei, H., & Zhai, X. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c03173 · Cited by 6
Characterization of Lysophospholipase D Activity in Mammalian Cell Membranes
Xie, Y., Ella, K. M., Gibbs, T. C., Yohannan, M. E., Knoepp, S. M., Balijepalli, P., Meier, G. P., & Meier, K. E. (2024) · Cells · doi:10.3390/cells13060520 · Cited by 5
Zhao, X., Guo, X., Mei, P., Qiu, W., Luo, Z., Lin, Q., Lu, Y., Yin, H. H., Wang, S., Liu, H., et al. (2023) · Nano Research · doi:10.1007/s12274-023-6030-2 · Cited by 5
Desroy, N., Borza, R., Heiermann, J., Triballeau, N., Joncour, A., Bienvenu, N., Hengeveld, W. J., Springer, J., Galien, R., Joosten, R. P., et al. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118181 · Cited by 4
Self-citationAmplex red assay, a standardized in vitro protocol to quantify the efficacy of autotaxin inhibitors
Stylianaki, E.-A., Magkrioti, C., Kaffe, E., Matralis, A. N., & Aidinis, V. (2025) · STAR Protocols · doi:10.1016/j.xpro.2025.103721 · Cited by 3
The role of lysophosphatidic acid and its receptors in corneal nerve regeneration
Kheyrollah, M., Brandt, N., Bräuer, A. U., Schrader, S., & Mertsch, S. (2024) · The Ocular Surface · doi:10.1016/j.jtos.2024.12.006 · Cited by 2
Emerging Concepts in Therapeutic Interventions for Idiopathic Pulmonary Fibrosis
Schott, C. A., Mohning, M. P., & Cooley, J. C. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2651-1937 · Cited by 2
Jeon, S., Kwon, J., Ko, H. G., Yoon, J., Kim, Y. A., Lee, J., Kang, M., & Kim, H. Y. (2025) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-025-00705-0 · Cited by 2
Diyaolu, A., Obi, P., Balijepalli, P., Meier, K. E., & Natesan, S. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013825 · Cited by 1
Jeon, S. W., Kwon, J., Ko, H. G., Yoon, J., Sohn, H. S., Yoon, J.-K., Bhang, S.-H., Kang, M.-H., & Kim, H. Y. (2026) · Biomaterials Research · doi:10.34133/bmr.0345 · Cited by 1
Linking the Autotaxin-LPA Axis to Medicinal Cannabis and the Endocannabinoid System
Eymery, M., Boumendjel, A., McCarthy, A. A., & Hausmann, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063212 · Cited by 1
Yan, J., Han, L., Ba, X., Shen, P., Lin, W., Li, T., Zhang, R., Yang, Y., Li, Y., Li, C., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6597839/v1 · Cited by 1
Booijink, R. S., Salgado-Polo, F., Jamieson, C. J., Anastassis Perrakis, A., & Bansal, R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.19.492626
Self-citationNeue Therapieverfahren für die idiopathische Lungenfibrose am Horizont
Artysh, N., & Prasse, A. (2023) · Zeitschrift für Pneumologie · doi:10.1007/s10405-023-00527-8
Janovicz, A., Majer, A., Kosztelnik, M., Geiszt, M., Chun, J. J. M., Ishii, S., Tigyi, G., Benyó, Z., & Ruisanchez, É. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231199081
Rai, P., Clark, C. J., Kardam, V., Womack, C. B., Thammathong, J., Norman, D. D., Tigyi, G., Bicker, K. L., Weissmiller, A. M., Dubey, K. D., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020597
Emery, M., Cuero, C. N., Bouazza, L., Internicola, C., Duboeuf, F., Aguirre, P. C., McCarthy, A. A., Machuca‐Gayet, I., Leblanc, R., & Peyruchaud, O. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.04.646839
Chen, W., Chen, X., Wang, Y., Guo, C., Yu, S., & We, Z. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1553136
Lin, J., Wang, S., Cao, L., Wang, L., Li, J., Tang, N., Jiao, C., Ma, J., Zhao, X., & Zhang, H. (2026) · Inflammation · doi:10.21203/rs.3.rs-7509054/v1
Beaumont, R. E., Flood, C., & Guest, D. J. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11219-2
Alkaline phosphatase superfamily members: new pieces of the choline metabolism puzzle
Lecornu, F., Mulard, E. D., Bessueille, L., Gerardin, D., Rautureau, G. J. P., Ballut, L., & Magne, D. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156625
Zhang, P., Qu, S., Liu, J., Zhan, K., Yang, X., & Lei, H. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119030
Lipid-Regulated State Transitions in Inflammation, Regeneration, and Chronic Disease
Al-Ewaidat, O. A., & Naffaa, M. M. (2026) · Lipidology · doi:10.3390/lipidology3020020
Wei, W., Liu, R., Su, D., Ping, Y., Song, Y., & Ai, Z. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135981
Autotaxin inhibitors: an updated patent review (2021-present)
Wei, X., Zhao, C., Cao, Z., Tan, Z., & Zhai, X. (2026) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2026.2704850
Nagata, W., & Takada, K. (2026) · Inflammation Research · doi:10.1007/s00011-026-02337-z
Liu, E., Ding, J., Jiang, Y., Zhou, Y., Xu, L., He, Z., Zhou, W., & Song, Z. (2026) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.70174
BindingDB (2025) · UC San Diego · doi:10.7270/q2k078wh
Metadata
- Authors
- Salgado-Polo, F., Borza, R., Matsoukas, M.-T., Marsais, F., Jagerschmidt, C., Waeckel, L., Moolenaar, W. H., Ford, P., Heckmann, B., & Perrakis, A.
- Affiliations
- The Netherlands Cancer Institute (NL)
- University of West Attica (GR)
- Galapagos (France) (FR)
- Galapagos (Belgium) (BE)
- ORCID
- Venue
- Cell Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 30
- Issue
- 1
- Pages
- 69-84.e14
- ISSN
- 2451-9448 (ISSN-L)
- 2451-9456
- OpenAlex
- W4316036667
- Cited by
- 45
- References
- 70
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 13 · 2023: 7
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell chemical biology (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- SSRN Electronic Journal (acceptedVersion)
- PubMed (publishedVersion)
- DORA PSI (Paul Scherrer Institute) (submittedVersion, cc-by)
- Funders
- Engineering and Physical Sciences Research Council
- Swansea University
- Merck KGaA
- Universiteit Utrecht
- Ministerie van Volksgezondheid, Welzijn en Sport
- KWF Kankerbestrijding
- Galápagos
- Oncode Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- autotaxin, lysophosphatidic acid, LPA receptors, P2Y receptors, G protein-coupled receptor signaling, pulmonary fibrosis, radiation-induced pulmonary fibrosis, lung fibroblasts, receptor selectivity
- MeSH terms
- Animals, Fibroblasts, Lysophospholipids, Pulmonary Fibrosis, Signal Transduction, Receptors, Lysophosphatidic Acid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
